Spectral AI Schedules 2025 Second Quarter Financial Results and Conference Call
Spectral AI (NASDAQ: MDAI), a company specializing in AI-driven medical diagnostics for wound care through their DeepView® System, has scheduled its Q2 2025 financial results announcement for August 12, 2025 after market close.
The company will host a conference call at 5:00 PM ET on the same day to discuss the results. Investors can participate by dialing 833-630-1956 (U.S.) or 412-317-1837 (International). A simultaneous webcast will be available on the company's investor relations website.
Spectral AI (NASDAQ: MDAI), azienda specializzata in diagnostica medica basata sull'IA per la cura delle ferite tramite il sistema DeepView®, ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 per il 12 agosto 2025 dopo la chiusura dei mercati.
La società terrà una conference call alle 17:00 ET dello stesso giorno per discutere i risultati. Gli investitori potranno partecipare chiamando il numero 833-630-1956 (USA) o 412-317-1837 (internazionale). Sarà inoltre disponibile una webcast simultanea sul sito web delle relazioni con gli investitori della società.
Spectral AI (NASDAQ: MDAI), una empresa especializada en diagnósticos médicos impulsados por IA para el cuidado de heridas mediante su sistema DeepView®, ha programado el anuncio de sus resultados financieros del segundo trimestre de 2025 para el 12 de agosto de 2025 después del cierre del mercado.
La compañía realizará una llamada conferencia a las 5:00 PM ET el mismo día para discutir los resultados. Los inversores pueden participar llamando al 833-630-1956 (EE.UU.) o al 412-317-1837 (internacional). También habrá una transmisión simultánea disponible en el sitio web de relaciones con inversores de la empresa.
Spectral AI (NASDAQ: MDAI)는 DeepView® 시스템을 통해 상처 치료를 위한 AI 기반 의료 진단을 전문으로 하는 회사로, 2025년 8월 12일 시장 마감 후 2025년 2분기 재무 실적 발표를 예정하고 있습니다.
회사는 같은 날 오후 5시(동부 시간)에 실적에 대해 논의하는 컨퍼런스 콜을 진행할 예정입니다. 투자자들은 미국 내 833-630-1956 또는 국제 전화 412-317-1837로 참여할 수 있습니다. 동시에 회사 투자자 관계 웹사이트에서 웹캐스트도 제공됩니다.
Spectral AI (NASDAQ : MDAI), une entreprise spécialisée dans le diagnostic médical assisté par IA pour les soins des plaies via son système DeepView®, a programmé l'annonce de ses résultats financiers du deuxième trimestre 2025 pour le 12 août 2025 après la clôture du marché.
La société tiendra une conférence téléphonique à 17h00 ET le même jour pour discuter des résultats. Les investisseurs peuvent participer en appelant le 833-630-1956 (États-Unis) ou le 412-317-1837 (international). Un webinaire simultané sera également disponible sur le site des relations investisseurs de la société.
Spectral AI (NASDAQ: MDAI), ein Unternehmen, das sich auf KI-gestützte medizinische Diagnostik für die Wundversorgung mit seinem DeepView®-System spezialisiert hat, hat die Veröffentlichung der Finanzergebnisse für das zweite Quartal 2025 am 12. August 2025 nach Börsenschluss geplant.
Das Unternehmen wird am selben Tag um 17:00 Uhr ET eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen. Investoren können teilnehmen, indem sie die Nummer 833-630-1956 (USA) oder 412-317-1837 (international) wählen. Eine gleichzeitige Webcast-Übertragung wird auf der Investor-Relations-Website des Unternehmens verfügbar sein.
- None.
- None.
DALLAS, July 30, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System and focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will report financial results for the second quarter ended June 30, 2025 on Tuesday, August 12, 2025 after the close of the stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time that day to discuss the results.
Investors interested in participating in the live call can dial:
- 833-630-1956 – U.S.
- 412-317-1837 – International
A simultaneous webcast of the call may be accessed online from the Events & Presentations section of the Investor Relations page of the Company’s website at https://investors.spectral-ai.com/news-events/events.
About Spectral AI
Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns. The Company is working to revolutionize the management of wound care by “Seeing the Unknown®” with its DeepView System. The DeepView System is being developed as a predictive device to offer clinicians an objective and immediate assessment of a burn wound’s healing potential prior to treatment or other medical intervention. With algorithm-driven results and a goal of exceeding the current standard of care in the future, the DeepView System is expected to provide fast and accurate treatment insight towards value care by improving patient outcomes and reducing healthcare costs. For more information about the DeepView System, visit www.spectral-ai.com.
Forward-Looking Statements
Certain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995, including statements regarding the Company’s strategy, plans, objectives, initiatives and financial outlook. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. As such, readers are cautioned not to place undue reliance on any forward-looking statements.
Investors should carefully consider the foregoing factors, and the other risks and uncertainties described in the “Risk Factors” sections of the Company’s filings with the SEC, including the Registration Statement and the other documents filed by the Company. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements.
For Media and Investor Relations, please contact:
David Kugelman
Atlanta Capital Partners LLC
(866) 692-6847 Toll Free - U.S. & Canada
(404) 281-8556 Mobile and WhatsApp
Email: dk@atlcp.com
FAQ
When will Spectral AI (MDAI) release Q2 2025 earnings?
How can investors join Spectral AI's Q2 2025 earnings call?
Where can I watch Spectral AI's Q2 2025 earnings webcast?
What is Spectral AI's main product?
